- Home
- SNOA vs TTNP Comparison
SNOA vs TTNP Comparison
Compare SNOA & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNOA
- TTNP
- Stock Information
- Founded
- SNOA 1999
- TTNP 1991
- Country
- SNOA United States
- TTNP United States
- Employees
- SNOA N/A
- TTNP N/A
- Industry
- SNOA Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNOA Health Care
- TTNP Health Care
- Exchange
- SNOA Nasdaq
- TTNP Nasdaq
- Market Cap
- SNOA 6.4M
- TTNP 5.9M
- IPO Year
- SNOA 2007
- TTNP 1996
- Fundamental
- Price
- SNOA $2.90
- TTNP $4.40
- Analyst Decision
- SNOA
- TTNP
- Analyst Count
- SNOA 0
- TTNP 0
- Target Price
- SNOA N/A
- TTNP N/A
- AVG Volume (30 Days)
- SNOA 25.5K
- TTNP 44.1K
- Earning Date
- SNOA 06-17-2025
- TTNP 08-14-2025
- Dividend Yield
- SNOA N/A
- TTNP N/A
- EPS Growth
- SNOA N/A
- TTNP N/A
- EPS
- SNOA N/A
- TTNP N/A
- Revenue
- SNOA $14,288,000.00
- TTNP N/A
- Revenue This Year
- SNOA $38.54
- TTNP N/A
- Revenue Next Year
- SNOA N/A
- TTNP N/A
- P/E Ratio
- SNOA N/A
- TTNP N/A
- Revenue Growth
- SNOA 12.20
- TTNP N/A
- 52 Week Low
- SNOA $1.75
- TTNP $3.03
- 52 Week High
- SNOA $9.37
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SNOA 38.85
- TTNP 48.35
- Support Level
- SNOA $2.81
- TTNP $4.23
- Resistance Level
- SNOA $3.45
- TTNP $4.65
- Average True Range (ATR)
- SNOA 0.13
- TTNP 0.27
- MACD
- SNOA -0.05
- TTNP -0.03
- Stochastic Oscillator
- SNOA 10.77
- TTNP 30.67
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.